Immune Pharmaceuticals Inc. (IMNP) Declined -21.1% or -0.07 To Price $0.27 On Tuesday


Immune Pharmaceuticals Inc. (IMNP) declined -21.1% or -0.07 to $0.27. It is about 4.59 million shares traded, which is 1742.66% compare to the average total volume 263504. The market cap of IMNP is $8.71 million. The year to date change is -40.34%. The 52 week price range is from $0.27 to $3.43. Price of IMNP have changed -0.55% during last week. It have changed -0.43% over last month, -30.76% over last 3 months, -60.22% over last 6 months and -86.84% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for IMNP is 0.36. It is 33.33% above current price. The 200-day Moving Averages for IMNP is 0.81. It is 200.00% above current price. The 52-week High is 3.43. It is 1170.37% from the current price. The 52-week Low is 0.27. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of IMNP is 3.82 on 2018-04-30. Short % to float is 3.76%. There are some statistics of IMNP. It is has market cap $8.71 million. The share outstanding is 31.90 million. The average volume is 263504. The percent of top 15 Institution holding is 2.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of IMNP is -304.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of IMNP is -103.76%.


Tags:

Share this post